How Patents Flagged for Delisting Can Still Delay Generic Competition

This Viewpoint discusses the legal entanglements that can block generic drug competition on patents flagged for delisting.

from JAMA Health Forum New Online https://ift.tt/RxaZLdV

Comments

Popular posts from this blog

Skilled Nursing Facilities and Sufficient Bed Capacity